Enhancing treatment precision through radiobiological modeling for evaluating complex VMAT plans in prostate and head-and-neck cancers-Reference-Cited by-同舟云学术

Enhancing treatment precision through radiobiological modeling for evaluating complex VMAT plans in prostate and head-and-neck cancers

Published:2024-08-19 Issue: Volume: Page:
ISSN:2190-7188
Container-title:Health and Technology
language:en
Short-container-title:Health Technol.

Author:

EL Kafhali Morad^ORCID,Khalis Mohammed,Tahmasbi Marziyeh,Sebihi Rajaa,Talbi Mohammed,Youssoufi Moulay Ali,Moujahid Soukaina,Elkhatib Aziz,Ghosne Nadia

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12553-024-00901-3.pdf

Reference53 articles.

1. El Naqa I, Pater P, Seuntjens J. Monte Carlo role in radiobiological modelling of radiotherapy outcomes. Phys Med Biol. 2012;57. https://doi.org/10.1088/0031-9155/57/11/R75.

2. Mille MM, Jung JW, Lee C, Kuzmin GA, Lee C. Comparison of normal tissue dose calculation methods for epidemiological studies of radiotherapy patients.J. Radiol. Prot. 2018;38:775–92. https://doi.org/10.1088/1361-6498/aabd4f.

3. Smilowitz JB, Das IJ, Feygelman V, Fraass BA, Kry SF, Marshall IR, Mihailidis DN, Ouhib Z, Ritter T, Snyder MG, Fairobent L. AAPM Medical Physics Practice Guideline 5.a. commissioning and QA of Treatment Planning Dose calculations - Megavoltage Photon and Electron beams. J Appl Clin Med Phys. 2015;16:14–34. https://doi.org/10.1120/jacmp.v16i5.5768.

4. Zarepisheh M, Uribe-Sanchez AF, Li N, Jia X, Jiang SB. A multicriteria framework with voxel-dependent parameters for radiotherapy treatment plan optimization. Med Phys. 2014;41. https://doi.org/10.1118/1.4866886.

5. Hernandez V, Hansen CR, Widesott L, Bäck A, Canters R, Fusella M, Götstedt J, Jurado-Bruggeman D, Mukumoto N, Kaplan LP, Koniarová I, Piotrowski T, Placidi L, Vaniqui A, Jornet N. What is plan quality in radiotherapy? The importance of evaluating dose metrics, complexity, and robustness of treatment plans. Radiother Oncol. 2020;153:26–33. https://doi.org/10.1016/j.radonc.2020.09.038.